New Type of Immunotherapy Approved for Melanoma
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a first-of-its kind immunotherapeutic, talimogene laherparepvec or T-Vec...
Author:
Karen Honey, PhD
Earlier this week, the U.S. Food and Drug Administration (FDA) approved a first-of-its kind immunotherapeutic, talimogene laherparepvec or T-Vec...
Yesterday, Onivyde, which is a nanotherapeutic form of the conventional chemotherapeutic irinotecan, was approved by the U.S. Food and...
Late last week, the U.S. Food and Drug Administration (FDA) announced that it had approved the use of the...
The number of anticancer immunotherapeutics approved by the U.S. Food and Drug Administration (FDA) is rising rapidly. In fact,...
Earlier this week, new ground was broken in the field of cancer immunotherapy when the U.S. Food and Drug...
Last week, the U.S. Food and Drug Administration (FDA) approved a new combination of drugs, formulated together in a...
Later today, more than 200 scientists working diligently to advance the field of epigenetics research will convene in Atlanta...
Colorectal cancer screening prevented about 33,000 cases of colorectal cancer and saved the lives of about 16,000 U.S. residents...
Last week, the U.S. Food and Drug Administration (FDA) approved a new anticancer therapeutic called sonidegib (Odomzo) for patients...
Every year, the American Association for Cancer Research (AACR) organizes a robust program of educational workshops for early-career investigators...